Success Story: Successful RFE Response Leads to NIW Approval for a Plastic Surgery Researcher

Client’s Testimonial:

 

“Thank you very much for the great news and your support in the process!”

 


 

On September 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher Scientist in the Field of Plastic Surgery (Approval Notice).

 


 

General Field: Plastic Surgery

 

Position at the Time of Case Filing: Postdoctoral Researcher

 

Country of Origin: Iran

 

State of Residence at the Time of Filing: Pennsylvania

 

Approval Notice Date: September 27th, 2026

 

Processing Time: 6 months, 4 days (Premium Processing Requested)

 


 

Case Summary:

 

This NIW petition was filed for a plastic surgery researcher whose proposed endeavor centered on advancing the understanding, diagnosis, and treatment of complex congenital disorders. The client’s work investigated the foundational genetic mechanisms underlying these conditions and sought to translate those findings into improved diagnostic and therapeutic strategies. The record connected this specialized research to broader public health priorities, including the national prevalence and systemic healthcare burden of congenital anomalies in the United States.


When USCIS issued a Request for Evidence (RFE) on May 11th, North America Immigration Law Group (Chen Immigration Law Associates) prepared a response designed to reinforce the NIW case under the Matter of Dhanasar framework. The response presented a broader evidentiary record connecting the endeavor to U.S. healthcare needs, the prevention and treatment of birth defects, and the economic consequences associated with these conditions. It further explained how earlier diagnosis and more targeted treatment strategies could improve patient care and help address the broader healthcare burden associated with congenital disorders.


Another important part of the RFE strategy was demonstrating that the client was well positioned to continue the proposed work through objective evidence of past achievement. The response documented 15 peer-reviewed journal articles, 10 first-authored abstracts, and 1 first-authored book chapter. The client’s published research had received 314 citations at the time of the initial filing and 345 citations by the time of the RFE response. Citation benchmarking provided additional context for this record, showing that two of the client’s papers ranked among the top 1% of most-cited articles for their respective publication years.


North America Immigration Law Group also emphasized evidence showing that the significance of the client’s work extended beyond publication and citation totals. Independent researchers had actively relied on the client’s findings to advance subsequent studies involving clinical applications, biomaterials, and developmental mechanisms. By demonstrating this independent use across the scientific community, the petition established a record of practical and scholarly influence beyond citation metrics alone. The response further highlighted that the client’s research had received funding from the National Institutes of Health, providing additional evidence of the broader significance of the client’s research area.


Following the RFE response, USCIS approved the NIW petition on September 27th, 2026. By bringing together the client’s publication and citation record, independent use of the research, and federally supported work. North America Immigration Law Group presented a comprehensive response addressing the petition’s eligibility under the NIW framework. The approval allowed the client to continue pursuing research aimed at improving the scientific and clinical approaches.